HGF and neoplasm: Troglitazone required Rab7 to prevent HGF-induced protease secretion and tumor cell invasion in vitro. In addition, Rab7 shRNA expressing cells formed larger tumors in vivo, which exhibited increased proliferation, decreased apoptosis, and increased invasive capacity into surrounding tissues.